Episode Details
Back to Episodes347: More HHS upheaval, 23andMe's bankruptcy, and AI for cancer survival
Published 1 year, 6 months ago
Description
Adam, Elaine, and Allison discuss the Trump administration’s plan for huge job cuts and a restructuring of the country’s top health care agencies, the approval of the first drug to treat a devastating rare disease, and the bankruptcy of 23andMe. Then, they bring on the chief executive of startup Altis Labs to discuss new data from a study they conducted with AstraZeneca on an AI tool for cancer drug development.